BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8472488)

  • 1. Case report: accumulation of 99mTc-hydroxymethylene diphosphonate by liver metastases of prostatic adenocarcinoma.
    Mannion RA; Johnson M
    Clin Radiol; 1993 Mar; 47(3):209-10. PubMed ID: 8472488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Visualisation of prostate cancer liver metastases on a 99mTc-MDP bone scan].
    Loaiza Góngora JL; Hervás Benito I; Bello Arques P; Vercher Conejero JL; Mateo Navarro A
    Rev Esp Med Nucl; 2009; 28(2):80. PubMed ID: 19406055
    [No Abstract]   [Full Text] [Related]  

  • 3. [Benign myocardial uptake of 99mTc-HMDP in prostate carcinoma: based on three cases].
    Poblete García VM; Rodado Marina S; García Vicente A; Soriano Castrejón A
    Rev Esp Med Nucl; 2003; 22(1):35-9. PubMed ID: 12550032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of a bone imaging agent in liver metastases from prostate carcinoma.
    Haseman MK
    Clin Nucl Med; 1983 Oct; 8(10):488-9. PubMed ID: 6228362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Super bone scan: bone metastases of prostate cancer.
    Shikino K; Ikusaka M; Hirota Y; Sato E
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25228679
    [No Abstract]   [Full Text] [Related]  

  • 6. Extensive bone metastases in a patient with prostatic adenocarcinoma and normal serum prostate-specific antigen and prostatic acid phosphatase.
    Yuksel M; Cermik TF; Kaya M; Salan A; Ustun F; Salihoglu YS; Yigitbasi ON; Berkarda S
    Clin Nucl Med; 2001 Nov; 26(11):962. PubMed ID: 11595863
    [No Abstract]   [Full Text] [Related]  

  • 7. The headless bone scan: an uncommon manifestation of metastatic superscan in carcinoma of the prostate.
    Massie JD; Sebes JI
    Skeletal Radiol; 1988; 17(2):111-3. PubMed ID: 3363378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of technetium-99m hydroxymethylene diphosphonate scans in localizing bone metastases of differentiated thyroid carcinoma.
    Tenenbaum F; Schlumberger M; Bonnin F; Lumbroso J; Aubert B; Benali H; Parmentier C
    Eur J Nucl Med; 1993 Dec; 20(12):1168-74. PubMed ID: 8299652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded 99mTc-methylene diphosphonate (MDP) bone scan.
    Pollen JJ; Witztum K; Basarab R
    Urology; 1984 Dec; 24(6):632-8. PubMed ID: 6239440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic prostatic pulmonary nodules with normal bone image.
    Petras AF; Wollett FC
    J Nucl Med; 1983 Nov; 24(11):1026-7. PubMed ID: 6226768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone metastases from poorly differentiated adenocarcinoma of the prostate diagnosed by In-111 ProstaScint (Capromab Pendetide) images with negative results of Tc-99m MDP bone scan and without significant elevation of prostate-specific antigen.
    Norris S; Halkar R; Galt J; Petros J; Keller J
    Clin Nucl Med; 1999 Nov; 24(11):905-7. PubMed ID: 10551485
    [No Abstract]   [Full Text] [Related]  

  • 12. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
    Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
    Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical uptake of 99m Tc-HMDP in a patient with metastatic liver disease.
    Moya Espinosa P; Amrani Raissouni T; Ramos Moreno E; Martínez del Valle Torres MD; Ortega Lozano SJ; Jiménez-Hoyuela García JM
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):350-1. PubMed ID: 23169390
    [No Abstract]   [Full Text] [Related]  

  • 14. Sub-super bone scan caused by bone marrow involvement of prostate cancer.
    Seo Y; Shuke N; Yamamoto W; Usui K; Aburano T
    Ann Nucl Med; 1999 Oct; 13(5):351-4. PubMed ID: 10582806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cold technetium-99m HDP and hot gallium-67 images of metastatic adenocarcinoma of bone.
    Ahn CS; Tow DE
    Clin Nucl Med; 1988 May; 13(5):371-2. PubMed ID: 3390986
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone agent localization in hepatic metastases.
    Shih WJ; Han JK; Magoun S; Wierzbinski B
    J Nucl Med Technol; 1999 Mar; 27(1):38-40. PubMed ID: 10322573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
    Pollen JJ; Witztum KF; Ashburn WL
    AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the Usefulness of Bone Scan Index Calculated From 99m-Technetium- Hydroxymethylene Diphosphonate (
    Higashiyama S; Yoshida A; Kawabe J
    Curr Med Imaging; 2021; 17(1):89-96. PubMed ID: 32484112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone metastases demonstrated by pentavalent Tc-99m DMSA and Tc-99m HMDP.
    Hirano T; Otake H
    Clin Nucl Med; 1997 Sep; 22(9):640-1. PubMed ID: 9298304
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatoma accumulation of Tc-99m hydroxymethylene diphosphonate.
    Burke T; Fukumoto D; Cohen A; Johnson AC
    Clin Nucl Med; 1983 Jun; 8(6):275. PubMed ID: 6307579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.